Family Legacy, Inc. Eli Lilly & CO Transaction History

Family Legacy, Inc.

$277 Million
Q2 2024

A detailed history of Family Legacy, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Family Legacy, Inc. holds 7,781 shares of LLY stock, worth $6.88 Million. This represents 2.54% of its overall portfolio holdings.

Number of Shares

7,781

Previous 8,459 8.02%

Holding current value

$6.88 Million

Previous $6.58 Million 7.05%

% of portfolio

2.54%

Previous 2.38%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $491,461 - $616,329	-678 Reduced 8.02%	7,781 $7.04 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $734,920 - $983,219	-1,241 Reduced 12.79%	8,459 $6.58 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $240,537 - $283,561	-458 Reduced 4.51%	9,700 $5.65 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $149,536 - $206,159	-344 Reduced 3.28%	10,158 $5.46 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $173,967 - $232,614	-496 Reduced 4.51%	10,502 $4.93 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $40,692 - $47,791	131 Added 1.21%	10,998 $3.78 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $55,628 - $64,817	-173 Reduced 1.57%	10,867 $3.98 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $46,843 - $53,383	158 Added 1.45%	11,040 $3.57 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $40,137 - $47,126	-144 Reduced 1.31%	10,882 $3.52 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $147,385 - $183,162	-628 Reduced 5.39%	11,026 $3.16 Million
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $17,988 - $22,323	80 Added 0.69%	11,654 $3.06 Million
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $10,193 - $12,544	46 Added 0.4%	11,574 $2.71 Million
Q2 2021 Jul 28, 2021	BUY	$180.55 - $233.54 $361 - $467	2 Added 0.02%	11,528 $2.75 Million
Q1 2021 Apr 09, 2021	BUY	$164.32 - $212.72 $821 - $1,063	5 Added 0.04%	11,526 $2.15 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $14,350 - $18,989	110 Added 0.96%	11,521 $1.95 Million
Q3 2020 Oct 09, 2020	BUY	$146.22 - $169.13 $7,018 - $8,118	48 Added 0.42%	11,411 $1.69 Million
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $14,869 - $17,895	-109 Reduced 0.95%	11,363 $1.87 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $31,310 - $38,753	263 Added 2.35%	11,472 $1.59 Million
Q4 2019 Jan 14, 2020	BUY	$106.92 - $132.43 $142,203 - $176,131	1,330 Added 13.46%	11,209 $1.5 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $308,089 - $335,121	2,885 Added 41.25%	9,879 $1.11 Million
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $55,505 - $64,789	501 Added 7.72%	6,994 $775,000
Q1 2019 May 06, 2019	SELL	$111.31 - $131.02 $5,454 - $6,419	-49 Reduced 0.75%	6,493 $826,000
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $46,066 - $51,608	435 Added 7.12%	6,542 $757,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $6,010 - $7,511	70 Added 1.16%	6,107 $655,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $5,299 - $6,081	70 Added 1.17%	6,037 $515,000
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $8,534 - $10,074	115 Added 1.97%	5,967 $462,000
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $479,512 - $514,332	5,852	5,852 $494,000

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $840B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Legacy, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Legacy, Inc. with notifications on news.

Account

Family Legacy, Inc. Eli Lilly & CO Transaction History